High Cell Surface Death Receptor Expression Determines Type I Versus Type II Signaling-Reference-Cited by-同舟云学术

High Cell Surface Death Receptor Expression Determines Type I Versus Type II Signaling

Published:2011-10 Issue:41 Volume:286 Page:35823-35833
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Meng Xue Wei,Peterson Kevin L.,Dai Haiming,Schneider Paula,Lee Sun-Hee,Zhang Jin-San,Koenig Alexander,Bronk Steve,Billadeau Daniel D.,Gores Gregory J.,Kaufmann Scott H.

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference75 articles.

1. CD95L/FasL and TRAIL in Tumour Surveillance and Cancer Therapy

2. The Many Roles of FAS Receptor Signaling in the Immune System

3. Following TRAIL’s path in the immune system

4. Apoptosis by Death Factor

5. Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) Pathway Signaling

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correction: High cell surface death receptor expression determines type I versus type II signaling;Journal of Biological Chemistry;2022-05

2. Therapeutics targeting BCL2 family proteins;Mechanisms of Cell Death and Opportunities for Therapeutic Development;2022

3. Strength Training Modulates Prostate of Wistar Rats Submitted to High-Fat Diet;Reproductive Sciences;2020-06-29

4. Chemotherapy-induced pyroptosis is mediated by BAK/BAX-caspase-3-GSDME pathway and inhibited by 2-bromopalmitate;Cell Death & Disease;2020-04

5. Current overview on the clinical update of Bcl-2 anti-apoptotic inhibitors for cancer therapy;European Journal of Pharmacology;2019-11